The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry
Open accessAbstract
Immunoassays have made it possible to measure dozens of individual proteins and other analytes in human samples for help in establishing the diagnosis and prognosis of disease. In too many cases the results of those measurements are misleading and can lead to unnecessary treatment or missed opportunities for therapeutic interventions. These cases stem from problems inherent to immunoassays performed with human samples, which include a lack of concordance across platforms, autoantibodies, anti-reagent antibodies, and the high-dose hook effect. Tandem mass spectrometry may represent a detection method capable of alleviating many of the flaws inherent to immunoassays. We review our understanding of the problems associated with immunoassays on human specimens and describe methodologies using tandem mass spectrometry that could solve some of those problems. We also provide a critical discussion of the potential pitfalls of novel mass spectrometric approaches in the clinical laboratory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
Ion Suppression in Mass Spectrometry
Annesley, T. M. (2003) · Clinical Chemistry · doi:10.1373/49.7.1041 · Cited by 1,591
Electrospray interface for liquid chromatographs and mass spectrometers
Whitehouse, C. M., Dreyer, R. N., Yamashita, M., & Fenn, J. B. (1985) · Analytical Chemistry · doi:10.1021/ac00280a023 · Cited by 1,512
Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins
Anderson, L., & Hunter, C. L. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500331-mcp200 · Cited by 1,230
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells
Rush, J., Moritz, A., Lee, K. A., Guo, A., Goss, V. L., Spek, E. J., Zhang, H., Zha, X.-M., Polakiewicz, R. D., & Comb, M. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1046 · Cited by 1,124
Anderson, N. L., Anderson, N. G., Haines, L. R., Hardie, D. B., Olafson, R. W., & Pearson, T. W. (2004) · Journal of Proteome Research · doi:10.1021/pr034086h · Cited by 804
Mass spectrometry for proteomics
Han, X., Aslanian, A., & Yates, J. R. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.07.024 · Cited by 734
Siva, N. (2008) · Nature Biotechnology · doi:10.1038/nbt0308-256b · Cited by 622
Human Anti-Animal Antibody Interferences in Immunological Assays
Kricka, L. J. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.7.942 · Cited by 586
IMMUNOASSAY OF ENDOGENOUS PLASMA INSULIN IN MAN
YALOW, R. S., & BERSON, S. A. (1996) · Obesity Research · doi:10.1002/j.1550-8528.1996.tb00274.x · Cited by 460
Cited by
Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions
Picotti, P., & Aebersold, R. (2012) · Nature Methods · doi:10.1038/nmeth.2015 · Cited by 1,302
Revisiting biomarker discovery by plasma proteomics
Geyer, P. E., Holdt, L. M., Teupser, D., & Mann, M. (2017) · Molecular Systems Biology · doi:10.15252/msb.20156297 · Cited by 917
The Clinical Plasma Proteome: A Survey of Clinical Assays for Proteins in Plasma and Serum
Anderson, N. L. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.126706 · Cited by 562
The emergence of peptides in the pharmaceutical business: From exploration to exploitation
Uhlig, T., Kyprianou, T., Martinelli, F. G., Oppici, C. A., Heiligers, D., Hills, D., Calvo, X. R., & Verhaert, P. (2014) · EuPA Open Proteomics · doi:10.1016/j.euprot.2014.05.003 · Cited by 456
A targeted proteomics–based pipeline for verification of biomarkers in plasma
Whiteaker, J. R., Lin, C., Kennedy, J., Hou, L., Trute, M., Sokal, I., Yan, P., Schoenherr, R. M., Zhao, L., Voytovich, U. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1900 · Cited by 364
Whiteaker, J. R., Zhao, L., Anderson, L., & Paulovich, A. G. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900254-mcp200 · Cited by 323
Mass spectrometry and immunoassay: how to measure steroid hormones today and tomorrow
Taylor, A. E., Keevil, B., & Huhtaniemi, I. T. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0338 · Cited by 320
Bioanalytical Chemistry of Cytokines–a Review
Stenken, J. A., & Poschenrieder, A. J. (2015) · Analytica Chimica Acta · doi:10.1016/j.aca.2014.10.009 · Cited by 302
Clinical potential of mass spectrometry-based proteogenomics
Zhang, B., Whiteaker, J. R., Hoofnagle, A. N., Baird, G. S., Rodland, K. D., & Paulovich, A. G. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0135-7 · Cited by 210
Self-citationKennedy, J. J., Abbatiello, S. E., Kim, K., Yan, P., Whiteaker, J. R., Lin, C., Kim, J. S., Zhang, Y., Wang, X., Ivey, R. G., et al. (2014) · Nature Methods · doi:10.1038/nmeth.2763 · Cited by 184
LC–MS/MS analysis of steroids in the clinical laboratory
Keevil, B. G. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.04.009 · Cited by 149
Agger, S. A., Marney, L. C., & Hoofnagle, A. N. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.152264 · Cited by 143
“One approach to calibration makes the assumptions that (1) protein digestion goes to completion, (2) peptides are detected to the same extent from sample to sample, and (3) the response (peak area of endogenous peptide divided by peak area of the internal standard) of the peptide is linear across the measurement range.”
BackgroundSelf-citationHenderson, C. M., Lutsey, P. L., Misialek, J. R., Laha, T. J., Selvin, E., Eckfeldt, J. H., & Hoofnagle, A. N. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.244541 · Cited by 140
Self-citationHoofnagle, A. N., Becker, J. O., Oda, M. N., Cavigiolio, G., Mayer, P., & Vaisar, T. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.173856 · Cited by 140
Self-citationNeubert, H., Shuford, C. M., Olah, T. V., Garofolo, F., Schultz, G. A., Jones, B. R., Amaravadi, L., Laterza, O. F., Xu, K., & Ackermann, B. L. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvz022 · Cited by 109
Biomedical Mass Spectrometry in Today's and Tomorrow's Clinical Microbiology Laboratories
van Belkum, A., Welker, M., Erhard, M., & Chatellier, S. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00420-12 · Cited by 100
“The use of high-performance liquid chromatography (HPLC) in tandem with MS facilitates the detection of a variety of antibody species and even antibody-antigen complexes (17).”
Strathmann, F. G., Schulte, S., Goerl, K., & Petron, D. J. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.01.028 · Cited by 98
“Major limitations in antibody-based assays have been well documented [43,44].”
BackgroundTimsina, J., Gomez-Fonseca, D., Wang, L., Do, A., Western, D., Alvarez, I., Aguilar, M., Pastor, P., Henson, R. L., Herries, E., et al. (2022) · Journal of Alzheimer’s Disease · doi:10.3233/jad-220399 · Cited by 68
van den Broek, I., Fu, Q., Kushon, S., Kowalski, M. P., Millis, K., Percy, A., Holewinski, R. J., Venkatraman, V., & Van Eyk, J. E. (2017) · Clinical Mass Spectrometry · doi:10.1016/j.clinms.2017.08.004 · Cited by 62
Cilento, E. M., Jin, L., Stewart, T., Shi, M., Sheng, L., & Zhang, J. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14635 · Cited by 60
Hoofnagle, A. N. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.134049 · Cited by 57
Self-citationBaker-Nigh, A. T., Mawuenyega, K. G., Bollinger, J. G., Ovod, V., Kasten, T., Franklin, E. E., Liao, F., Jiang, H., Holtzman, D., Cairns, N. J., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721779 · Cited by 54
“The potential interferences include the high-dose hook effect, specificity shortcomings, autoantibodies, and anti-reagent antibodies (38).”
BackgroundThe role of corticosteroid-binding globulin in the evaluation of adrenal insufficiency
Verbeeten, K. C., & Ahmet, A. H. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2017-0270 · Cited by 51
Lassman, M. E., McLaughlin, T. M., Somers, E. P., Stefanni, A. C., Chen, Z., Murphy, B. A., Bierilo, K. K., Flattery, A. M., Wong, K. K., Castro‐Perez, J. M., et al. (2012) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.5296 · Cited by 51
van den Broek, I., Smit, N. P. M., Romijn, F. P. H. T. M., van der Laarse, A., Deelder, A. M., van der Burgt, Y. E. M., & Cobbaert, C. M. (2013) · Journal of Proteome Research · doi:10.1021/pr400763d · Cited by 49
Prasad, S., Lassetter, B., Welker, K. M., & Mehta, P. H. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104373 · Cited by 41
“Fourth and lastly, in line with suggestions from others (Hoofnagle and Wener, 2009; Schultheiss et al., 2018) we recommend the use of MS for salivary hormone measurement given its advantages over IAs including (i) better analytical specificity that is not contingent on antibody performance and is less sensitive to mat…”
BackgroundApolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia
Renee Ruhaak, L., van der Laarse, A., & Cobbaert, C. M. (2019) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563219827620 · Cited by 38
“Mass spectrometry (MS) is a strategic (antibody-independent) technology for highly multiplexed protein quantification, that has recently entered the medical laboratory.(26,27) Multiple clinically relevant (apolipo)proteins can simultaneously be enzymatically digested,(28) upon which proteinspecific signature peptides…”
BackgroundSmit, N. P. M., Romijn, F. P. H. T. M., van den Broek, I., Drijfhout, J. W., Haex, M., van der Laarse, A., van der Burgt, Y. E. M., & Cobbaert, C. M. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.06.015 · Cited by 32
“A general drawback of immunoassays is their high development cost, the unimarker kit formats and the fact that the protein biomarkers of interest are detected indirectly via antibodies recognizing specific epitopes on the proteins [14].”
BackgroundLaforest, S., Pelletier, M., Denver, N., Poirier, B., Nguyen, S., Walker, B. R., Durocher, F., Homer, N. Z. M., Diorio, C., Andrew, R., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz268 · Cited by 23
Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening
De Jesús, V. R., Simms, D. A., Schiffer, J., Kennedy, M., Mei, J. V., & Hannon, W. H. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.06.029 · Cited by 20
Quality requirements for quantitative clinical chemistry proteomics
(2014) · Translational Proteomics · doi:10.1016/j.trprot.2013.10.001 · Cited by 11
Froehlich, B. C., Popp, R., Sobsey, C. A., Ibrahim, S., LeBlanc, A. M., Mohammed, Y., Aguilar‐Mahecha, A., Poetz, O., Chen, M. X., Spatz, A., et al. (2020) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.202000034 · Cited by 9
Non-standardized protein background in IVF media linked to serum-derived albumin supplementation
Nezvedová, M., Porokh, V., Bočková, T., Pustka, V., Kyjovská, D., Maierová, B., Kloudová, S., Otevřel, P., & Holubcová, Z. (2025) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-025-03616-0 · Cited by 6
Metadata
- Authors
- Hoofnagle, A. N., & Wener, M. H.
- Venue
- Journal of Immunological Methods
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 347
- Issue
- 1-2
- Pages
- 3-11
- ISSN
- 0022-1759 (ISSN-L)
- OpenAlex
- W2066322883
- Cited by
- 561
- References
- 46
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.